{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:19:31Z","timestamp":1772165971497,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,9]],"date-time":"2023-08-09T00:00:00Z","timestamp":1691539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People\u2019s Republic of China","doi-asserted-by":"crossref","award":["2016YFC0105207"],"award-info":[{"award-number":["2016YFC0105207"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences","award":["2019XK320046"],"award-info":[{"award-number":["2019XK320046"]}]},{"name":"Peking Union Medical College Postgraduate Education Reform Program","award":["No. 10023201900104"],"award-info":[{"award-number":["No. 10023201900104"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-A-036"],"award-info":[{"award-number":["2022-PUMCH-A-036"]}]},{"name":"National High Level Hospital Clinical Research Funding","award":["No.2022-PUMCH-B-052"],"award-info":[{"award-number":["No.2022-PUMCH-B-052"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Women's Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>This study aimed to report clinical practice patterns of postoperative radiotherapy for stage I to II endometrial carcinoma (EC) patients treated in 13 Chinese medical centers.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included early stage EC patients treated by hysterectomy and adjuvant RT between 2003 and 2017 from 13 institutions. Patients were classified into 4 risk groups based on ESMO-ESGO-ESTRO recommendations (2014).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 1,227 cases were analyzed. Along the 15\u00a0years of the study, an increasing tendency was found towards administration for vaginal brachytherapy (VBT) alone, while the proportion of external beam pelvic radiotherapy (EBRT) alone remained stable in the corresponding period. When radiation modalities were stratified by risk groups, proportion of VBT alone significantly increased in all risk groups. The higher the risk, the later VBT became the main adjuvant treatment modality. However, EBRT alone or with VBT remained the main adjuvant method for high-risk patients.<\/jats:p>\n                    <jats:p>There were 13 dose-fractionation schemes for VBT alone with the scheme of 30\u00a0Gy in 6 fractions prescribed at 0.5cm under the vaginal mucosa accounting for most. There were 17 schemes for VBT boost and the most common schedule was 10\u00a0Gy in 2 fractions. The upper 3\u20135cm part of vagina was the most frequent target. 89.6% of the practitioners performed two-dimensional VBT technique. The median dose for EBRT was 50\u00a0Gy. From 2003 to 2017, conventional radiotherapy was gradually replaced by three-dimensional conformal radiotherapy modality and intensity modulated radiotherapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We report a significant shift from EBRT to VBT alone for high-intermediate-risk, intermediate-risk and low-risk EC patients from 2003 to 2017 while EBRT remained the main radiation modality for high-risk early stage patients. There has been remarkable heterogeneity among VBT dose fractionation schedules across China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The clinical trial ID was ChiCTR-PRC-17010712. It was authorized by the Institutional Review Board of Peking Union Medical College Hospital (N0. S-K139).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12905-023-02548-0","type":"journal-article","created":{"date-parts":[[2023,8,8]],"date-time":"2023-08-08T20:01:50Z","timestamp":1691524910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Practice patterns of adjuvant radiotherapy in women with stage I to II endometrial carcinoma: a real-world multi-institutional analysis in China"],"prefix":"10.1186","volume":"23","author":[{"given":"Wenhui","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiejun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianli","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoge","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fengjv","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanshu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuquan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4903-9489","authenticated-orcid":false,"given":"Xiaorong","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lichun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lijuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,9]]},"reference":[{"issue":"2","key":"2548_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, et al. Cancer statistics in China, 2015. Cancer J Clin. 2016;66(2):115\u201332. https:\/\/doi.org\/10.3322\/caac.21338.","journal-title":"Cancer J Clin"},{"issue":"1","key":"2548_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.brachy.2016.04.005","volume":"16","author":"MM Harkenrider","year":"2017","unstructured":"Harkenrider MM, Block AM, Alektiar KM, Gaffney DK, Jones E, Klopp A, et al. American Brachytherapy Task Group Report: adjuvant vaginal brachytherapy for early-stage endometrial cancer: a comprehensive review. Brachytherapy. 2017;16(1):95\u2013108. https:\/\/doi.org\/10.1016\/j.brachy.2016.04.005.","journal-title":"Brachytherapy"},{"issue":"1","key":"2548_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/annonc\/mdv484","volume":"27","author":"N Colombo","year":"2016","unstructured":"Colombo N, Creutzberg C, Amant F, Bosse T, Gonz\u00e1lez-Mart\u00edn A, Ledermann J, et al. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up. Ann Oncol. 2016;27(1):16\u201341. https:\/\/doi.org\/10.1093\/annonc\/mdv484.","journal-title":"Ann Oncol"},{"key":"2548_CR4","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.radonc.2020.11.018","volume":"154","author":"N Concin","year":"2021","unstructured":"Concin N, Matias-Guiu X, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Radiother Oncol. 2021;154:327\u201353. https:\/\/doi.org\/10.1016\/j.radonc.2020.11.018.","journal-title":"Radiother Oncol"},{"issue":"9658","key":"2548_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/s0140-6736(08)61767-5","volume":"373","author":"P Blake","year":"2009","unstructured":"Blake P, Swart AM, Orton J, Kitchener H, Whelan T, Lukka H, et al. Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet (London England). 2009;373(9658):137\u201346. https:\/\/doi.org\/10.1016\/s0140-6736(08)61767-5.","journal-title":"Lancet (London England)"},{"issue":"3","key":"2548_CR6","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","volume":"92","author":"HM Keys","year":"2004","unstructured":"Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic Oncology Group study. Gynecol Oncol. 2004;92(3):744\u201351. https:\/\/doi.org\/10.1016\/j.ygyno.2003.11.048.","journal-title":"Gynecol Oncol"},{"issue":"9717","key":"2548_CR7","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/s0140-6736(09)62163-2","volume":"375","author":"RA Nout","year":"2010","unstructured":"Nout RA, Smit VT, Putter H, J\u00fcrgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, et al. Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial. Lancet (London England). 2010;375(9717):816\u201323. https:\/\/doi.org\/10.1016\/s0140-6736(09)62163-2.","journal-title":"Lancet (London England)"},{"issue":"3","key":"2548_CR8","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.ijrobp.2005.03.007","volume":"63","author":"AN Scholten","year":"2005","unstructured":"Scholten AN, van Putten WL, Beerman H, Smit VT, Koper PC, Lybeert ML, et al. Postoperative radiotherapy for stage 1 endometrial carcinoma: long-term outcome of the randomized PORTEC trial with central pathology review. Int J Radiat Oncol Biol Phys. 2005;63(3):834\u20138. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.03.007.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"2548_CR9","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/s41416-018-0310-8","volume":"119","author":"BG Wortman","year":"2018","unstructured":"Wortman BG, Creutzberg CL, Putter H, J\u00fcrgenliemk-Schulz IM, Jobsen JJ, Lutgens L, et al. Ten-year results of the PORTEC-2 trial for high-intermediate risk endometrial carcinoma: improving patient selection for adjuvant therapy. Br J Cancer. 2018;119(9):1067\u201374. https:\/\/doi.org\/10.1038\/s41416-018-0310-8.","journal-title":"Br J Cancer"},{"issue":"4","key":"2548_CR10","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.ijrobp.2015.08.023","volume":"93","author":"SM de Boer","year":"2015","unstructured":"de Boer SM, Nout RA, J\u00fcrgenliemk-Schulz IM, Jobsen JJ, Lutgens LC, van der Steen-Banasik EM, et al. Long-term impact of Endometrial Cancer diagnosis and treatment on health-related quality of Life and Cancer survivorship: results from the Randomized PORTEC-2 Trial. Int J Radiat Oncol Biol Phys. 2015;93(4):797\u2013809. https:\/\/doi.org\/10.1016\/j.ijrobp.2015.08.023.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"2548_CR11","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.ijrobp.2005.04.038","volume":"63","author":"W Small Jr","year":"2005","unstructured":"Small W Jr, Erickson B, Kwakwa F. American Brachytherapy Society survey regarding practice patterns of postoperative irradiation for endometrial cancer: current status of vaginal brachytherapy. Int J Radiat Oncol Biol Phys. 2005;63(5):1502\u20137. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.04.038.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2548_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.brachy.2015.09.012","volume":"15","author":"MM Harkenrider","year":"2016","unstructured":"Harkenrider MM, Grover S, Erickson BA, Viswanathan AN, Small C, Kliethermes S, et al. Vaginal brachytherapy for postoperative endometrial cancer: 2014 survey of the american Brachytherapy Society. Brachytherapy. 2016;15(1):23\u20139. https:\/\/doi.org\/10.1016\/j.brachy.2015.09.012.","journal-title":"Brachytherapy"},{"issue":"5","key":"2548_CR13","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.brachy.2016.06.012","volume":"15","author":"A Modh","year":"2016","unstructured":"Modh A, Ghanem AI, Burmeister C, Rasool N, Elshaikh MA. Trends in the utilization of adjuvant vaginal brachytherapy in women with early-stage endometrial carcinoma: results of an updated period analysis of SEER data. Brachytherapy. 2016;15(5):554\u201361. https:\/\/doi.org\/10.1016\/j.brachy.2016.06.012.","journal-title":"Brachytherapy"},{"issue":"9213","key":"2548_CR14","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1016\/s0140-6736(00)02139-5","volume":"355","author":"CL Creutzberg","year":"2000","unstructured":"Creutzberg CL, van Putten WL, Koper PC, Lybeert ML, Jobsen JJ, W\u00e1rl\u00e1m-Rodenhuis CC, et al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet (London England). 2000;355(9213):1404\u201311. https:\/\/doi.org\/10.1016\/s0140-6736(00)02139-5.","journal-title":"Lancet (London England)"},{"issue":"4","key":"2548_CR15","first-page":"419","volume":"56","author":"J Aalders","year":"1980","unstructured":"Aalders J, Abeler V, Kolstad P, Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet Gynecol. 1980;56(4):419\u201327.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2548_CR16","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1016\/j.ijrobp.2011.04.014","volume":"82","author":"B Sorbe","year":"2012","unstructured":"Sorbe B, Horvath G, Andersson H, Boman K, Lundgren C, Pettersson B. External pelvic and vaginal irradiation versus vaginal irradiation alone as postoperative therapy in medium-risk endometrial carcinoma\u2013a prospective randomized study. Int J Radiat Oncol Biol Phys. 2012;82(3):1249\u201355. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.04.014.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2548_CR17","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ijrobp.2006.09.004","volume":"67","author":"A Fayed","year":"2007","unstructured":"Fayed A, Mutch DG, Rader JS, Gibb RK, Powell MA, Wright JD, et al. Comparison of high-dose-rate and low-dose-rate brachytherapy in the treatment of endometrial carcinoma. Int J Radiat Oncol Biol Phys. 2007;67(2):480\u20134. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.09.004.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"2548_CR18","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.ygyno.2008.12.029","volume":"113","author":"GM Cannon","year":"2009","unstructured":"Cannon GM, Geye H, Terakedis BE, Kushner DM, Connor JP, Hartenbach EM, et al. Outcomes following surgery and adjuvant radiation in stage II endometrial adenocarcinoma. Gynecol Oncol. 2009;113(2):176\u201380. https:\/\/doi.org\/10.1016\/j.ygyno.2008.12.029.","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2548_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/0360-3016(90)90133-5","volume":"19","author":"ME Randall","year":"1990","unstructured":"Randall ME, Wilder J, Greven K, Raben M. Role of intracavitary cuff boost after adjuvant external irradiation in early endometrial carcinoma. Int J Radiat Oncol Biol Phys. 1990;19(1):49\u201354. https:\/\/doi.org\/10.1016\/0360-3016(90)90133-5.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"2548_CR20","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/s0360-3016(98)00173-4","volume":"42","author":"KM Greven","year":"1998","unstructured":"Greven KM, D\u2019Agostino RB Jr, Lanciano RM, Corn BW. Is there a role for a brachytherapy vaginal cuff boost in the adjuvant management of patients with uterine-confined endometrial cancer? Int J Radiat Oncol Biol Phys. 1998;42(1):101\u20134. https:\/\/doi.org\/10.1016\/s0360-3016(98)00173-4.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"2548_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/s1470-2045(18)30079-2","volume":"19","author":"SM de Boer","year":"2018","unstructured":"de Boer SM, Powell ME, Mileshkin L, Katsaros D, Bessette P, Haie-Meder C, et al. Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial. Lancet Oncol. 2018;19(3):295\u2013309. https:\/\/doi.org\/10.1016\/s1470-2045(18)30079-2.","journal-title":"Lancet Oncol"},{"issue":"21","key":"2548_CR22","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1200\/jco.18.01575","volume":"37","author":"ME Randall","year":"2019","unstructured":"Randall ME, Filiaci V, McMeekin DS, von Gruenigen V, Huang H, Yashar CM, et al. Phase III trial: Adjuvant pelvic radiation therapy versus vaginal brachytherapy plus paclitaxel\/carboplatin in high-intermediate and high-risk early stage Endometrial Cancer. J Clin Oncol. 2019;37(21):1810\u20138. https:\/\/doi.org\/10.1200\/jco.18.01575.","journal-title":"J Clin Oncol"},{"issue":"3","key":"2548_CR23","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1097\/igc.0000000000000900","volume":"27","author":"EA Reynaers","year":"2017","unstructured":"Reynaers EA, Jutzi L, Ezendam NP, Kwon JS, Pijnenborg JM. Improved outcome of High-Grade, early 1-Stage Endometrioid Endometrial Carcinoma with Adjuvant Chemotherapy and Radiotherapy: comparison of 2 treatment strategies. Int J Gynecol Cancer. 2017;27(3):467\u201372. https:\/\/doi.org\/10.1097\/igc.0000000000000900.","journal-title":"Int J Gynecol Cancer"},{"issue":"9","key":"2548_CR24","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1097\/igc.0000000000000900","volume":"28","author":"E Smogeli","year":"2018","unstructured":"Smogeli E, Cvancarova M, Wang Y, Davidson B, Kristensen G, Lindemann K. Clinical outcome of patients with high-risk Endometrial Carcinoma after treatment with Chemotherapy only. Int J Gynecol Cancer. 2018;28(9):1789\u201395. https:\/\/doi.org\/10.1097\/igc.0000000000000900.","journal-title":"Int J Gynecol Cancer"},{"issue":"4","key":"2548_CR25","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.brachy.2019.03.001","volume":"18","author":"BJ Ager","year":"2019","unstructured":"Ager BJ, Francis SR, Do OA, Huang YJ, Soisson AP, Dodson MK, et al. Do vaginal recurrence rates differ among adjuvant vaginal brachytherapy regimens in early-stage endometrial cancer? Brachytherapy. 2019;18(4):453\u201361. https:\/\/doi.org\/10.1016\/j.brachy.2019.03.001.","journal-title":"Brachytherapy"},{"issue":"1","key":"2548_CR26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.brachy.2011.08.005","volume":"11","author":"W Small Jr","year":"2012","unstructured":"Small W Jr, Beriwal S, Demanes DJ, Dusenbery KE, Eifel P, Erickson B, et al. American Brachytherapy Society consensus guidelines for adjuvant vaginal cuff brachytherapy after hysterectomy. Brachytherapy. 2012;11(1):58\u201367. https:\/\/doi.org\/10.1016\/j.brachy.2011.08.005.","journal-title":"Brachytherapy"}],"container-title":["BMC Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02548-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12905-023-02548-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12905-023-02548-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,20]],"date-time":"2023-11-20T15:04:53Z","timestamp":1700492693000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcwomenshealth.biomedcentral.com\/articles\/10.1186\/s12905-023-02548-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,9]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2548"],"URL":"https:\/\/doi.org\/10.1186\/s12905-023-02548-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-2076874\/v1","asserted-by":"object"}]},"ISSN":["1472-6874"],"issn-type":[{"value":"1472-6874","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,9]]},"assertion":[{"value":"18 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Institutional Review Board (IRB) of Peking Union Medical College Hospital (N0. S-K139) at Oct. 24, 2016. As it was a retrospective study, the IRB waived the need for obtaining the informed consent. We confirm that the methods were performed under the relevant regulations and guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Declarations of interest: none.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The trial was retrospectively registered at 2017.02.23 and the registration number is ChiCTR-PRC-17010712.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial registration number"}}],"article-number":"417"}}